Clinical Trials Logo

Fasciitis, Plantar clinical trials

View clinical trials related to Fasciitis, Plantar.

Filter by:

NCT ID: NCT06348017 Completed - Control Group Clinical Trials

Frequency of Neuropathic Pain in Patients With Plantar Fasciitis

Start date: October 19, 2023
Phase:
Study type: Observational

Study Design This prospective cross-sectional study was undertaken between November 2023 and March 2024. Written and verbal informed consent was obtained from all patients. The study protocol was approved by University Human Research Ethics Committee (AEŞH-EK 1-2023-612). Patients While 106 patients who applied to the City Hospital Physical Medicine and Rehabilitation outpatient clinic with heel pain that had been present for at least six months, received foot radiography and were diagnosed with PF were included in the study as a patient group; 100 patients who did not have foot pain and had musculoskeletal pain for at least 6 months were included in the study as a control group, between November 2023 and March 2024. All the participants were aged 18 to 65 years. Patients with a history of diabetes, hypothyroidism and CKD, a history of malignancy, with vasculitis, neurological diseases that may cause neuropathic pain, lumbar discopathy, those with a previous history of fracture or surgery in the heel area, received injections or ESWT treatment due to heel pain in the last 3 months, rheumatic diseases that may affect pain such as rheumatoid arthritis, ankylosing spondylitis, fibromyalgia, and severe circulatory disorders on the side with pain, were excluded from the study. The study was commenced after obtaining the approval of the local ethics committee and informed consent of the participants. All patients' personal information (age, gender, occupation, education information), general health information (smoking and alcohol use information, known chronic disease history, body mass index), severity of heel pain and when it started were recorded. While the Foot Function Index (FFI) scale, which evaluates the functionality of the foot, was applied to the patient group; the Visual Analog Scale (VAS), which evaluates pain intensity, the Pain-DETECT scale, which evaluates neuropathic pain, and the Central Sensitization Scale (CSI), which evaluates central sensitization, were applied to the patient and control groups. The details of the implementation of the instruments are as follows:

NCT ID: NCT06319066 Not yet recruiting - Fasciitis, Plantar Clinical Trials

Customized Foot Orthoses With Orthotic Wedges for Plantar Heel Pain

Start date: April 1, 2024
Phase: N/A
Study type: Interventional

The present study will use a randomized controlled trial (RCT) to determine the effectiveness of customized foot orthosis (CFO) for the treatment of patients with PHP. Three treatment groups including the CFO without wedge, the CFO with wedge type 1 (W1), and the CFO with wedge type 2 (W2) will be randomly assigned to each participant by a computer-generated randomization. The opaque-sealed envelopes will be used to allocate the groups of participant.

NCT ID: NCT06318910 Not yet recruiting - Fasciitis, Plantar Clinical Trials

Customized Foot Orthoses on Muscle Activity During Standing and Gait in Plantar Heel Pain

Start date: April 1, 2024
Phase: N/A
Study type: Interventional

The present study will use a randomized controlled trial (RCT) to determine the effectiveness of customized foot orthosis (CFO) for the treatment of patients with PHP. Three treatment groups including the CFO without wedge, the CFO with wedge type 1 (W1), and the CFO with wedge type 2 (W2) will be randomly assigned to each participant by a computer-generated randomization. The opaque-sealed envelopes will be used to allocate the groups of participant.

NCT ID: NCT06310122 Not yet recruiting - Plantar Fascitis Clinical Trials

Effect of Extracorporeal Shockwave Therapy on Gait Parameters in Patients With Planter Fascitis

Start date: March 12, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is : - to determine the effect of extracorporeal shockwave on pain intensity in patients with plantar fasciitis. - to determine the effect of extracorporeal shockwave on foot function in patients with plantar fasciitis. - to determine the effect of extracorporeal shockwave on gait parameters in patients with plantar fasciitis

NCT ID: NCT06305507 Not yet recruiting - Fasciitis, Plantar Clinical Trials

Differents Laser Applications on Plantar Fasciitis

Start date: March 2024
Phase:
Study type: Observational

The objective of this randomized controlled clinical trial (RCT) with a double-blind technique and longitudinal chronology, entitled "Effect of different laser applications on Plantar Fasciitis", is to evaluate and compare the effectiveness of laser therapy low-level (LLLT) in local spot mode versus sweep mode in the reduction of pain associated with plantar fasciitis. The main questions it seeks to answer are: - What is the comparative effectiveness between low-level laser therapy in local spot mode and sweep mode in reducing pain in patients with plantar fasciitis? - What are the optimal therapeutic parameters (session duration, frequency and power) for LLLT in both modes, maximizing pain reduction in patients with plantar fasciitis? Participants in this study will perform the following tasks: - Undergo low-level laser therapy sessions in local spot mode or sweep mode. - Comply with the instructions on the duration and frequency of the sessions. - Record the pain levels experienced before and after each session. The investigators will compare the group undergoing local spot mode low-level laser therapy with the group undergoing sweeping mode low-level laser therapy to evaluate whether there are significant differences in pain reduction effects.

NCT ID: NCT06284993 Recruiting - Clinical trials for Plantar Fasciitis, Chronic

Acupuncture of Different Treatment Frequency in Chronic Plantar Fasciitis

Start date: February 20, 2024
Phase: N/A
Study type: Interventional

Plantar fasciitis (PF) is one of the most common causes of heel pain, typically characterized by a sharp pain in the plantar aponeurosis, specifically near the insertion site close to the medial process of the calcaneal tuberosity. It has been reported that 1 in 10 people are expected to be affected by PF in their lifetime. A comprehensive internet-panel survey conducted among the adult United States population revealed the population-based prevalence of self-reported PF with pain in the last month was 0.85 percent. Approximately 1 million patients are diagnosed with this disease each year in the United States. PF was believed to be an acute inflammatory disease, but patient samples show it is actually a chronic degenerative process caused by various factors such as repetitive stresses, vascular and metabolic disorders, excess free radicals, high temperatures, genetic factors, and conditions like rheumatoid arthritis and spondyloarthropathies. PF may be associated with impaired health-related quality of life, including reduced life functioning, poor perceived health status and social isolation. Additionally, a recent study indicates that the annual cost associated with PF is $284 million. The first-line treatments recommended by guidelines for PF encompass physical therapy (including manual therapy, stretching, and others), pharmacological therapy (involving corticosteroids or platelet-rich plasma), and surgical treatment. However, the definite effects of physical therapy still require confirmation. Pharmacological treatments, such as local corticosteroid injections, exhibit a short maintenance period. Some studies indicate that the relief provided by corticosteroid injections lasts up to one month, yet its efficacy diminishes after 6 months. Surgical treatment is generally advised 6 to 12 months after unsuccessful conservative treatment, albeit with the drawback of higher costs, post-surgery recovery time, and patient apprehension. Acupuncture is one of the most common complementary alternative therapy for the treatment of pain-related diseases such as musculoskeletal muscle, and recent guidelines recommend dry needling as a treatment for relief of plantar fasciitis, with a level of evidence of B. Dry acupuncture is different from acupuncture in terms of theoretical basis, therapeutic apparatus, technical operation and scope of indications, however, the American Alliance for Professional Acupuncture Safety also believes that dry needling falls under the umbrella of acupuncture, but under a different name. In addition, there are systematic evaluations that suggest acupuncture can be a safe and effective treatment for PF, and most of the trials in the systematic evaluations used 4-week treatment courses. Our prior study demonstrated that a 4-week intervention of both electroacupuncture and manual acupuncture resulted in improved pain outcomes among patients with PF. The frequency of acupuncture stands as a crucial factor influencing its efficacy. A study revealed that needling trials with negative results had a significantly lower frequency compared to those yielding positive results. Furthermore, several studies indicate that acupuncture once a week can be help in conditions such as simple obesity, functional dyspepsia, and overactive bladder in women. There is no universally accepted standard of frequency of treatment for many conditions, including PF. In China, patients with chronic diseases usually receive 3-5 acupuncture treatments per week. However, in most previous trials, individuals with chronic diseases received 1-2 needling sessions per week. An increase in the frequency of acupuncture means an increase in the pain, time, and financial investment associated with the acupuncture process. Therefore, it is critical to optimize the frequency of acupuncture to ensure the effectiveness and feasibility of the treatment while avoiding increasing the burden on the patient. Accordingly, we designed the current trial to compare the effects of different acupuncture sessions (1 session per week versus 3 sessions per week) in a randomized controlled trial (RCT) of chronic PF. The hypothesis is that 1 session per week compared with 3 sessions per week of electroacupuncture treatment over a total of 4 weeks of treatment will provide a similar effect on pain relief in chronic PF.

NCT ID: NCT06248853 Not yet recruiting - Plantar Fascitis Clinical Trials

Effect of Graston Technique on Planter Thickness in Patients With Planter Fasciitis

PF
Start date: February 10, 2024
Phase: N/A
Study type: Interventional

this study will be conducted to investigate the effect of Graston Technique on Planter Thickness in Patients With Planter Fasciitis

NCT ID: NCT06240507 Completed - Plantar Fascitis Clinical Trials

Posterior Tibial Nerve PRF vs Intralesional RFT for Painful Calcaneal Spur and Plantar Fasciitis

Start date: January 2, 2023
Phase: N/A
Study type: Interventional

This study aims to compare the efficacy of ultrasound (US)-guided posterior tibial nerve pulsed radiofrequency (PTN PRF) and fluoroscopy (FL)-guided intralesional radiofrequency thermocoagulation (RFT) for the treatment of painful calcaneal spur and plantar fasciitis refractory to conservative treatments. For this evaluation, a numerical rating (NRS) and the American Orthopedic Foot and Ankle Society (AOFAS) ankle hindfoot scores will be used before and after both interventions.

NCT ID: NCT06231199 Not yet recruiting - Plantar Fascitis Clinical Trials

Combined Effect of Foam Roller and Gastrocnemius Release on Plantar Fasciitis

MTP
Start date: January 25, 2024
Phase: N/A
Study type: Interventional

this study will be conducted to investigate the efficacy of combining foam roller and gastrocnemius release on pain intensity level, dorsi flexion range of motion of ankle joint ,dorsi flexion range of motion of big toe and foot function in subjects with plantar fasciitis.

NCT ID: NCT06175533 Recruiting - Plantar Fascitis Clinical Trials

Pain Improvement After Ultrasound Guided Continuous Radio Frequency 60 Degree for Plantar Fasciitis

Start date: December 1, 2023
Phase: N/A
Study type: Interventional

detailed changes after ultrasound guided cry for plantar fasciitis in regard pain score and plantar fascia AP diameter in ultrasound scan pre and 30 days post operation